139 related articles for article (PubMed ID: 35259451)
1. Risk factors for metastatic cutaneous squamous cell carcinoma: Refinement and replication based on 2 nationwide nested case-control studies.
Tokez S; Venables ZC; Hollestein LM; Qi H; Bramer EM; Rentroia-Pacheco B; van den Bos RR; Rous B; Leigh IM; Nijsten T; Mooyaart AL; Wakkee M
J Am Acad Dermatol; 2022 Jul; 87(1):64-71. PubMed ID: 35259451
[TBL] [Abstract][Full Text] [Related]
2. Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study.
Roscher I; Falk RS; Vos L; Clausen OPF; Helsing P; Gjersvik P; Robsahm TE
JAMA Dermatol; 2018 Apr; 154(4):428-434. PubMed ID: 29516080
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis.
Thompson AK; Kelley BF; Prokop LJ; Murad MH; Baum CL
JAMA Dermatol; 2016 Apr; 152(4):419-28. PubMed ID: 26762219
[TBL] [Abstract][Full Text] [Related]
4. Validation of four cutaneous squamous cell carcinoma staging systems using nationwide data.
Venables ZC; Tokez S; Hollestein LM; Mooyaart AL; van den Bos RR; Rous B; Leigh IM; Nijsten T; Wakkee M
Br J Dermatol; 2022 May; 186(5):835-842. PubMed ID: 34862598
[TBL] [Abstract][Full Text] [Related]
5. Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model.
Rentroia-Pacheco B; Tokez S; Bramer EM; Venables ZC; van de Werken HJG; Bellomo D; van Klaveren D; Mooyaart AL; Hollestein LM; Wakkee M
EClinicalMedicine; 2023 Sep; 63():102150. PubMed ID: 37662519
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Recurrence and Progression in Poorly Differentiated Cutaneous Squamous Cell Carcinomas: Insights from a Real-Life Experience.
Roccuzzo G; Orlando G; Rumore MR; Morrone A; Fruttero E; Caliendo V; Picciotto F; Sciarrillo A; Quaglino P; Cassoni P; Ribero S; Senetta R
Dermatology; 2024; 240(2):329-336. PubMed ID: 38008073
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system.
Jambusaria-Pahlajani A; Kanetsky PA; Karia PS; Hwang WT; Gelfand JM; Whalen FM; Elenitsas R; Xu X; Schmults CD
JAMA Dermatol; 2013 Apr; 149(4):402-10. PubMed ID: 23325457
[TBL] [Abstract][Full Text] [Related]
8. Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in England.
Venables ZC; Autier P; Nijsten T; Wong KF; Langan SM; Rous B; Broggio J; Harwood C; Henson K; Proby CM; Rashbass J; Leigh IM
JAMA Dermatol; 2019 Mar; 155(3):298-306. PubMed ID: 30484823
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for lymph node metastasis in cutaneous squamous cell carcinoma: a long-term retrospective study of Japanese patients.
Saito Y; Fujikawa H; Takatsuka S; Abe R; Takenouchi T
Int J Clin Oncol; 2021 Mar; 26(3):606-612. PubMed ID: 33175299
[TBL] [Abstract][Full Text] [Related]
10. A Sensitivity Meta-Analysis of Disease-Specific Death in Localized Cutaneous Squamous Cell Carcinoma.
Dessinioti C; Platsidaki E; Stratigos AJ
Dermatology; 2022; 238(6):1026-1035. PubMed ID: 35550380
[TBL] [Abstract][Full Text] [Related]
11. Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma.
Tokez S; Hollestein L; Louwman M; Nijsten T; Wakkee M
JAMA Dermatol; 2020 Dec; 156(12):1300-1306. PubMed ID: 33112377
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.
Burton KA; Ashack KA; Khachemoune A
Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors and Prognosis for Metastatic Cutaneous Squamous Cell Carcinoma: A Cohort Study.
Knuutila JS; Riihilä P; Kurki S; Nissinen L; Kähäri VM
Acta Derm Venereol; 2020 Sep; 100(16):adv00266. PubMed ID: 32930344
[TBL] [Abstract][Full Text] [Related]
14. Identifying Brigham and Women's Hospital stage T2a cutaneous squamous cell carcinomas at risk of poor outcomes.
Gupta N; Weitzman RE; Murad F; Koyfman SA; Smile TD; Chang MS; Maher JM; Schmults CD; Vidimos AT; Ruiz ES
J Am Acad Dermatol; 2022 Jun; 86(6):1301-1308. PubMed ID: 34864111
[TBL] [Abstract][Full Text] [Related]
15. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study.
Schmults CD; Karia PS; Carter JB; Han J; Qureshi AA
JAMA Dermatol; 2013 May; 149(5):541-7. PubMed ID: 23677079
[TBL] [Abstract][Full Text] [Related]
16. Clinical and histopathological evaluation of 50 acantholytic cutaneous squamous cell carcinomas: Analysis outcome in a retrospective case-control study.
Conde-Ferreirós A; Moyano-Bueno D; Santos-Briz Á; Revelles-Peñas L; Revilla-Nebreda D; Becerril-Andrés S; Román-Curto C; Cañueto J
J Cutan Pathol; 2022 Feb; 49(2):133-138. PubMed ID: 34363705
[TBL] [Abstract][Full Text] [Related]
17. Cumulative incidence and disease-specific survival of metastatic cutaneous squamous cell carcinoma: A nationwide cancer registry study.
Tokez S; Wakkee M; Kan W; Venables ZC; Mooyaart AL; Louwman M; Nijsten T; Hollestein LM
J Am Acad Dermatol; 2022 Feb; 86(2):331-338. PubMed ID: 34653569
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and timing of subsequent cutaneous squamous cell carcinoma in patients with cutaneous squamous cell carcinoma: A retrospective cohort study.
Rodriguez M; Beal BT; Manmohan M; Simmons E; Varra V; Xiong D; Eversman A; Briskin IN; Knackstedt T; Vidimos AT
J Am Acad Dermatol; 2021 Mar; 84(3):719-724. PubMed ID: 32861709
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous squamous cell carcinoma staging may influence management in users: A survey study.
Patel VA; McCullum C; Sparks AD; Schmults CD; Arron ST; Jambusaria-Pahlajani A
Cancer Med; 2022 Jan; 11(1):94-103. PubMed ID: 34796670
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.
Levine DE; Karia PS; Schmults CD
JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
